Target intelligence / Profile preview

Ceramide kinase-like protein (CERKL)

Target
CERKL
Molecular classification
Other (mRNA-binding protein with homology to lipid kinases), Enzyme homolog (does not show kinase activity), Autophagy regulator
01

Overview

Ceramide kinase-like protein (CERKL) is a gene primarily expressed in the retina whose mutations are linked to autosomal recessive retinal degenerations such as retinitis pigmentosa and cone-rod dystrophy[2][1]. Despite structural similarity to ceramide kinase, CERKL does not phosphorylate ceramide or other tested lipid substrates[2][3]. Instead, CERKL exerts crucial protective functions in retinal cells by binding mRNA and participating in mRNA metabolism, interacting with protein complexes related to translation, and associating with stress granules, P-bodies, and microtubules[1]. It also helps regulate autophagy by stabilizing SIRT1 and maintains mitochondrial/oxidative stress resistance through interaction with mitochondrial thioredoxin 2[2][4]. Disease-associated mutations in CERKL impair these protective roles, leading to progressive retinal degeneration and photoreceptor cell death[2][1][4]. No approved therapeutic drugs directly target CERKL, and its role is not as a classical enzyme or receptor, but rather as a multifunctional regulator critical for retinal health.

Other names
CERK like autophagy regulatorCERKLRP26ceramide kinase-like proteinceramide kinase like
02

Biological functions

Regulation of autophagymRNA binding and metabolismRegulation of apoptosis in photoreceptorsInteraction with mitochondrial function and redox balanceMaintenance of cellular response to oxidative stress
03

Disease associations

Retinal degeneration (including retinitis pigmentosa)Cone-rod dystrophyNeurodegenerative retinal diseases
04

Safety considerations

Mutations lead to retinal degeneration and photoreceptor lossLoss-of-function compromises cytoprotective effects in retina

Beyond the preview

Go deeper on Ceramide kinase-like protein (CERKL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ceramide kinase-like protein (CERKL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call